Details for New Drug Application (NDA): 062901
✉ Email this page to a colleague
NDA 062901 describes UNASYN, which is a drug marketed by Pfizer and is included in two NDAs. It is available from one supplier. Additional details are available on the UNASYN profile page.
The generic ingredient in UNASYN is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.
The generic ingredient in UNASYN is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.
Summary for 062901
| Tradename: | UNASYN |
| Applicant: | Pfizer |
| Ingredient: | ampicillin sodium; sulbactam sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL | ||||
| Approval Date: | Nov 23, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL | ||||
| Approval Date: | Feb 27, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
